Waiv

Series-A
waiv.com AI & Machine Learning
Total Funding $33M
Latest Round $33M Series-A
Last Announced Apr 24, 2026
Investors Undisclosed
Decision Makers Profile Active

About Waiv

Catalyzing precision medicine with AI-enabled tests that accelerate biomarker discovery & detection, outcome prediction, and treatment-response assessment across oncology.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website waiv.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $33,000,000 · Series-A

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Waiv.

Funding History

1 Round
Series-A equity · Apr 24, 2026

Founders & Leadership

2

Lionel Guillou

Co-founder & CSTO

Work email & phone locked Unlock →

Meriem Sefta

CEO & Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts